ADARx Pharmaceuticals Patents – Insights & Stats (Updated 2023)

ADARx Pharmaceuticals has a total of 34 patents globally, out of which no patents have been granted. Of these 34 patents, more than 91% patents are active. Australia and Canada is where ADARx Pharmaceuticals has filed the maximum number of patents, followed by Brazil. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of ADARx Pharmaceuticals.

ADARx Pharmaceuticals was founded in 2019. ADARx Pharmaceuticals is a biotechnology firm. The company creates a patented RNA targeting platform to treat a variety of diseases in the therapeutic domains, such as central nervous system, cardiometabolic, and genetic disorders.

Do read about some of the most popular patents of ADARx Pharmaceuticals which have been covered by us in this article and also you can find ADARx Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ADARx Pharmaceuticals patent portfolio.

How many patents does ADARx Pharmaceuticals have?

ADARx Pharmaceuticals has a total of 34 patents globally. These patents belong to 11 unique patent families. Out of 34 patents, 31 patents are active.

How Many Patents did ADARx Pharmaceuticals File Every Year?

ADARx Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantADARx Pharmaceuticals Applications FiledADARx Pharmaceuticals Patents Granted
202310
20229
202115

How many ADARx Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

ADARx Pharmaceuticals Patent Portfolio

How Many Patents did ADARx Pharmaceuticals File in Different Countries?

ADARx Pharmaceuticals Worldwide Patent Filing

Countries in which ADARx Pharmaceuticals Filed Patents

CountryPatent
Australia3
Canada3
Brazil2
United States of America2
New Zealand2
Singapore2
Taiwan2
Europe2
South Africa2
Israel2
Mexico2

Where are Research Centers of ADARx Pharmaceuticals   Patents Located?

The Research Center for ADARx Pharmaceuticals is the United States of America.

List of ADARx Pharmaceuticals patents

ADARx Pharmaceuticals PatentsTitle
US20230272391A1Adar Dependent Editing Compositions And Methods Of Use Thereof
US20230158059A1Prekallikrein-Modulating Compositions And Methods Of Use Thereof
EP4225322A1N-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
EP4189088A1Adar Dependent Editing Compositions And Methods Of Use Thereof
WO2023168296A3Cb1 Ligand Conjugated Compounds And Uses Thereof
WO2023196342A1Α 4Β 1/7 Integrin Ligand Conjugated Compounds And Uses Thereof
WO2023192630A2Angiotensinogen-Modulating Compositions And Methods Of Use Thereof
WO2023154896A3Trkb Ligand Conjugated Compounds And Uses Thereof
WO2023097291A1Complement Factor B-Modulating Compositions And Methods Of Use Thereof
WO2023056446A1Angiotensinogen-Modulating Compositions And Methods Of Use Thereof
WO2023056440A1Prekallikrein-Modulating Compositions And Methods Of Use Thereof
CA3216732A1Rna Silencing Agents And Methods Of Use
CA3198406A1N-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
CA3190477A1Adar Dependent Editing Compositions And Methods Of Use Thereof
AU2022257002A1Rna Silencing Agents And Methods Of Use
AU2021359017A1N-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
AU2021315812A1Adar Dependent Editing Compositions And Methods Of Use Thereof
MX2023004170ACompounds And Oligonucleotides Derived From N-Acetylgalactosamine (Galnac)
MX2023001257AEditing Compositions Dependent On Endogenous Adenosine Deaminase Acting On Ribonucleic Acid And Methods For Use Them.
TW202340463AComplement Factor B-Modulating Compositions And Methods Of Use Thereof
BR112023006564A2Compounds Derivatives Of N-Acetylgalactosamine (Gainac) And Oligonucleotides
TW202322825APrekallikrein-Modulating Compositions And Methods Of Use Thereof
IL302000AN-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
SG11202302717RAN-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
ZA202305007AN-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
BR112023001641A2Adar-Dependent Edition Compositions And Methods Of Using Them
IL300241AAdar Dependent Editing Compositions And Methods Of Use Thereof
SG11202300674RAAdar Dependent Editing Compositions And Methods Of Use Thereof
ZA202301603AAdar Dependent Editing Compositions And Methods Of Use Thereof
NZ799007AN-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
NZ796915AAdar Dependent Editing Compositions And Methods Of Use Thereof
WO2022221457A1Rna Silencing Agents And Methods Of Use
WO2022076922A1N-Acetylgalactosamine(Galnac)-Derived Compounds And Oligonucleotides
WO2022026928A1Adar Dependent Editing Compositions And Methods Of Use Thereof

What are ADARx Pharmaceuticals key innovation segments?

What Technologies are Covered by ADARx Pharmaceuticals?

The chart below distributes patents filed by ADARx Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where ADARx Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has ADARx Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by ADARx Pharmaceuticals?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.